Andrea E. Holmes, Ph.D., obtained her doctorate degree in organic chemistry at New York University and her post-doctorate at Columbia University where she held a national research fellowship through the Department of Chemistry and the College of Physicians & Surgeons in New York. She also holds courtesy associate professorship appointments at the University of Nebraska in Lincoln and the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska.
Her research interests are in drug detection methods, sensor design, organic synthesis and analysis of natural and synthetic compounds, designing nano-detection arrays for small molecules, conformational discrimination of biological molecules using circular dichroism, colorimetric detection of bacterial infections, and the synthesis of optical fluorescent brighteners.
Dr. Holmes has served as the President of the Nebraska American Chemical Society. She has received several distinguished national honors, including the National Research Service Award from the National Institutes of Health, the National Science Foundation Presidential Early Career Award, and the Henry Dreyfus Teacher Scholar Award. She served as an investigator and an executive management member on multiple funded projects involving nanotechnology, including a $20-million National Science Foundation Research Infrastructure Improvement award for nanohybrid materials research for novel detection technologies, including drug detection.
Dr. Holmes has acquired multi-million funding, including National Institutes of Health funding to implement cutting-edge research involving novel sensor design methods for in field deployment applications, such as law enforcement and Drug Enforcement Agency officers. Dr. Holmes also serves an expert consultant and investigator for Ansera Analytics on a project that is funded by the Department of Defense (Project title: Chemical Biological Radiological Nuclear and Explosives (CBRNE) Reconnaissance Sampling Kit).